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ABSTRACT. Krassioukov A, Eng JJ, Warburton DE, Teasell
, Spinal Cord Injury Rehabilitation Evidence Research Team. A
ystematic review of the management of orthostatic hypotension
fter spinal cord injury. Arch Phys Med Rehabil 2009;90:876-85.
Objective: To review systematically the evidence for the
anagement of orthostatic hypotension (OH) in patients with
pinal cord injuries (SCIs).
Data Sources: A key word literature search was conducted
f original and review articles as well as practice guidelines
sing Medline, CINAHL, EMBASE, and PsycInfo, and manual
earches of retrieved articles from 1950 to July 2008, to iden-
ify literature evaluating the effectiveness of currently used
reatments for OH.
Study Selection: Included randomized controlled trials
RCTs), prospective cohort studies, case-control studies, pre-
ost studies, and case reports that assessed pharmacologic and
onpharmacologic intervention for the management of OH in
atients with SCI.
Data Extraction: Two independent reviewers evaluated the
uality of each study, using the Physiotherapy Evidence Data-
ase score for RCTs and the Downs and Black scale for all
ther studies. Study results were tabulated and levels of evi-
ence assigned.
Data Synthesis: A total of 8 pharmacologic and 21 non-
harmacologic studies were identified that met the criteria. Of
hese 26 studies (some include both pharmacologic and non-
harmacologic interventions), only 1 pharmacologic RCT was
dentified (low-quality RCT producing level 2 evidence), in
hich midodrine was found to be effective in the management
f OH after SCI. Functional electrical stimulation was one of
he only nonpharmacologic interventions with some evidence
level 2) to support its utility.
Conclusions: Although a wide array of physical and phar-
acologic measures are recommended for the management of
H in the general population, very few have been evaluated for
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HE DEFINITION OF orthostatic hypotension is typically
accepted as a decrease in systolic blood pressure of
0mmHg or more, or a reduction in diastolic blood pressure of
0mmHg or more, on changing body position from a supine
osition to an upright posture, regardless of the presence of
ymptoms.1 Numerous studies have documented the presence
f OH after SCI.2-5 OH is more common in tetraplegia than
araplegia, with prevalence rates as high as 82% for tetraplegia
ersus 50% for those with paraplegia immediately post-SCI.5
his condition not only is evident in the acute period postinjury
ut also has persisted in a significant number of persons for
any years.6-8 Standard mobilization during physiotherapy
eg, sitting or standing) is reported to induce blood pressure
ecreases that are diagnostic of OH in 74% of patients with
CI, and which are accompanied by OH symptoms (like light-
eadedness or dizziness) (appendix 1) in 59% of patients with
CI.5 This in turn may have a negative impact on the ability of
ubjects with SCI to participate in rehabilitation. Current man-
gement approaches for the treatment of OH consist of phar-
acologic and nonpharmacologic interventions.
The low level of efferent sympathetic nervous activity and
he loss of reflex vasoconstriction after SCI are among the
ajor causes of OH. The decrease in arterial blood pressure
fter a change to an upright position in subjects with SCI
ppears to be related to excessive pooling of blood in the
bdominal viscera and lower extremities.2,6,9 The excessive
enous pooling in the lower extremities, and the reduced blood
olume in the intrathoracic veins, ultimately lead to a decrease
n end-diastolic volume, and thus a decrease in left ventricular
troke volume.10 A subsequent reduction in cardiac output and
rterial pressure may lead to tachycardia. However, this reflex
achycardia is often insufficient to compensate for the lowered
utput and pressure. Consequently, the pooling of blood in the
ower extremities and the decrease in blood pressure may result
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877ORTHOSTATIC HYPOTENSION AFTER SPINAL CORD INJURY, Krassioukovn a reduction in cerebral flow, which presents as the signs and
ymptoms of OH (see appendix 1).
In addition to central causes of OH after SCI, there also is
ome evidence suggesting that changes in the periphery, such
s upregulation of the potent vasodilator, NO, might contribute
o orthostatic intolerance in this population.11 In experimental
nimals, it has been demonstrated that NO synthase expression
s dysregulated after SCI.12 Furthermore, Wecht et al13 found
hat intravenous infusion of NO synthase inhibitors facilitates
he normalization of blood pressure in subjects with SCI.
Several other factors may predispose persons with SCI to
H, including low plasma volume, hyponatremia, and cardio-
ascular deconditioning caused by prolonged bed-rest (appen-
ix 2).2,5,6 In addition, the prevalence of OH is more common
n tetraplegia,2,7,8 and in persons who have sustained a trau-
atic SCI versus those whose cord damage has been nontrau-
atic, as with cervical spinal stenosis.14
Most of our understanding of the pathophysiology and man-
gement of OH is derived from the management of this con-
ition in subjects with central autonomic neurodegenerative
isorders (eg, multiple system atrophy, Parkinson disease) and
atients with peripheral autonomic disorders (eg, autonomic
eripheral neuropathies, pure autonomic failure).2,15 From pre-
ious studies in subjects without SCI, it is well established that
combination of patient education and the use of pharmaco-
ogic and nonpharmacologic modalities can lead to the suc-
essful management of OH. The therapeutic goal for manage-
ent of OH is not to normalize the blood pressure values;
ather, it is to ameliorate symptoms while avoiding side ef-
ects.16 The deleterious effects of low blood pressure such as a
reater risk of developing pressure ulcers as a result of reduced
issue perfusion,17 and an increased dependence on the renin-
ngiotensin system, as a result of renal hypoperfusion, provide
easons to consider normalizing blood pressure independent of
H symptoms. The current general approach in the manage-
ent of OH is to implement therapeutic interventions in stages,
ependent on the severity of symptoms.16 It is well known
rom previous studies in non-SCI populations that nonpharma-
ologic measures alone often are insufficient to render OH
symptomatic. However, given that the mechanisms of OH
evelopment appear to be different in patients with SCI, it is
mportant to assess the effectiveness of treatment strategies
pecific to patients with SCI. The following systematic review
as conducted to provide health care professionals with the
vidence that supports the efficacy of the various strategies
urrently used to prevent and manage OH in the SCI popula-
ion. In addition, identifying gaps in the evidence can help
irect research efforts to areas of priority. These findings were
art of the Spinal Cord Injury Rehabilitation Evidence project
the details of which are available at http://www.icord.org/
cire/).
METHODS
A key word literature search of original articles, previous
ractice guidelines, and review articles was conducted to iden-
ify literature published from 1950 to July 2008 evaluating the
ffectiveness of any treatment or therapy for OH in the SCI
opulation. The population key words spinal cord injury, para-
legia, and tetraplegia were individually paired with ortho-
tatic hypotension, orthostatic intolerance, and blood pressure.
tudies that did not have outcomes evaluating OH—like blood
ressure or OH symptoms (eg, light-headedness, dizziness)—
ere excluded.
The quality of each study was scored by 2 independent
eviewers. The 11-item PEDro18 was used to score RCTs. Note
hat question 1 (external validity, whether eligibility criteria sere specified) is not part of the final score. The PEDro score
omprises questions 2 through 11, which address internal va-
idity (eg, blinding of assessors), with higher scores (maximum
0) indicating better methodologic quality (9–10excellent;
–8good; 4–5fair; 4poor).19 A modified version of the
owns and Black evaluation tool20 was used to score trials that
ere not randomized. Again, higher scores indicate a better
uality study; for the modified version, the highest score that
ould be assigned to any study was 28.20
The description by Sackett et al21 of levels of evidence was
sed to draw conclusions about the level of evidence for the
ccumulated studies. Sackett’s21 levels of evidence were col-
apsed into 5 categories, whereby evidence was rated level 1 if
erived from good to excellent RCTs with PEDro scores of 6
r higher, level 2 if derived from RCTs with PEDro scores of
or less or from nonrandomized prospective controlled and
ohort studies, level 3 if derived from case-control studies,
evel 4 if derived from either pre-test/post studies or case
eries, and level 5 if gleaned from an observational report or
ase report involving a single subject or from clinical consen-
us.20 We did not require a minimum sample size because of
he relatively limited number of publications.
RESULTS
A total of 26 studies that met the criteria were identified and
valuated using either the PEDro evaluation tool, for RCTs, or
he modified Downs and Black tool, for all other studies. Eight
tudies7,22-28 addressed the pharmacologic management and 21
tudies examined the nonpharmacologic management of OH
fluid and salt: n37,26,28; pressure devices: n629-34; FES:
94,35-42; exercise: n343-45; some studies address multiple
reatments). One descriptive review on the nonpharmacologic
anagement of OH after SCI was also found.46
harmacologic Management of Orthostatic Hypotension
n Spinal Cord Injury
With the exception of 1 study (n231),7 the sample size for
ach of the studies was small (n1–7) (table 1).22-28
Midodrine. Midodrine is a selective alpha-adrenergic ag-
nist that exerts its actions via the activation of the alpha-
drenergic receptors of the arteriolar and venous vasculature,
roducing an increase in vascular tone and an elevation in
lood pressure. The peak effect of midodrine is 25 to 30
inutes, with a half-life of about 3 to 4 hours. Usual doses are
.5mg twice daily (at breakfast and lunch) or 3 times daily.
oses are increased quickly until a response occurs or a dose
f 30mg/d is attained.47 Midodrine does not cross the blood-
rain barrier and is therefore not associated with central nervous
ystem effects. The principal adverse effect of the peripherally
cting alpha-1 agonists is vasoconstriction. Other adverse ef-
ects include uterine contractions; mydriasis; arterial hyperten-
ion, especially in the supine position; palpitations; tachycar-
ia; and headaches.48 However, the benefits of midodrine in the
anagement of OH in subjects with SCI have been reported in
single level 2 RCT,22 2 level 4 studies,23,24 and 1 level 5
tudy.27
Even though the only controlled trial consisted of just 4
ubjects,22 the study was a rigorous, double-blinded, placebo-
ontrolled, randomized, crossover trial that included a within-
ubject design. Systolic blood pressure was increased during
eak exercise (3 of 4 subjects), and exercise performance also
as enhanced.
Fludrocortisone (Florinef). Fludrocortisone is a mineralo-
orticoid that stimulates the release of salt into the blood-
tream. It increases blood volume and may enhance the sensi-
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A
ivity of blood vessels to circulating catecholamines.49,50 The
tarting dose is 0.1mg daily. Blood pressure rises gradually
ver several days, with a peak effect at 1 to 2 weeks. Doses
hould be adjusted at weekly or biweekly intervals. Hypoka-
emia (low potassium) occurs in 50% of subjects and hypo-
agnesemia in 5%. These may need to be corrected with
upplements. Fludrocortisone should not be used in persons
ith congestive heart failure because of its marked effect on
odium retention. One level 4 case series,24 1 level 5 case
eport (n1),25 and 1 level 5 observational study7 described its




Total Sample Size Methods




Population: 4 patients with chronic, complete
Treatment: midodrine 5mg, 10mg, or placebo
capsule).
Double-blind, placebo-controlled cross-over d
Outcome measures: measure of cardiovascul
parameters during wheelchair ergometer te
Senard et al,23 1991; France
Downs and Black score11
Pre-post
N7
Population: 45-year-old man with chronic com
traumatic paraplegia; 6 male controls witho
Treatment: clonidine (150g, twice daily) and
(specific  1-agonist; 10mg, twice daily). He
assessed by blinded tester.
Outcome measures: blood pressure, heart pa
plasma catecholamine, -adrenoceptor sen
Barber et al,24 2000; USA
Downs and Black score7
Case series
N2
Population: 2 patients with acute complete m
tetraplegia.
Treatment: fludrocortisone acetate 0.1mg 4 ti
or midodrine 10mg 3 times a day.
Outcome measures: blood pressure, heart ra
symptoms of OH.
Frisbie and Steele,7 1997; USA
Downs and Black score18
Observational
N231
Population: SCI; ephedrine group: mean age,
duration of paralysis 2615y; no ephedrine
mean age, 5115.2y, 2213.5y postinjury.
Treatment: retrospective chart review of use
ephedrine (n30), salt supplementation (n
fludrocortisone (n3), or physical therapy.
Outcome measures: OH symptoms, serum so
urine osmolality.
Frisbie,28 2004; USA
Downs and Black score9
Observational
N4
Population: chronic, complete cervical tetrapl
grade A.
Treatment: evaluation of urinary salt and wat
relation to prescribed dose of ephedrine (d
from 0 to 100mg daily).
Outcome measures: severity of OH, urinary o
Mukand et al,27 2001; USA
Downs and Black score10
Case report
N1
Population: 21-year old man; SCI; traumatic;
tetraplegia; ASIA grade C, with symptomat
orthostatic hypotension.
Treatment: Midodrine (2.5–15mg 3 times a da
Outcome measures: blood pressure, and sym
OH.
Groomes and Huang,25 1991; USA
Downs and Black score9
Case report
N1
Population: 28-year-old with chronic C5 tetrap
Treatment: ergotamine (2mg), daily combine
fludrocortisone (.10–.05mg).
Outcome measures: blood pressure.
Muneta et al,26 1992; Japan
Downs and Black score9
Case report
N1
Population: 72-year-old woman with nontrau
and paroxysmal hypotension.
Treatment: several weeks of salt supplement
d), followed by L-DOPS (100mg up to 600m
Outcome measures: blood pressure, serum
catecholamines, plasma renin activity.
bbreviations: ASIA, American Spinal Injury Association; NE, norepinephrine.se in the treatment of OH within the SCI population. r
rch Phys Med Rehabil Vol 90, May 2009Barber et al24 found no effect of fludrocortisone on OH in 2
atients with SCI, while Groomes and Huang25 found an im-
rovement in 1 patient within 10 days of treatment. The other
tudy, conducted by Frisbie and Steele,7 combined fludrocor-
isone with other pharmacologic and physical agents in 3
atients; however, outcomes specific to this group were not
escribed, so the specific effects of fludrocortisone cannot be
iscerned.
Dihydroergotamine. Dihydroergotamine and ergotamine
oth are ergot alkaloids that interact with alpha-adrenergic




1. Midodrine 10mg elevated systolic blood pressure during exercise in
3 participants. Peak systolic blood pressure ranged from 90 to
126mmHg under baseline and placebo conditions, 114 to 148 after
5mg midodrine, and 104 to 200mmHg after 10mg.
2. Two participants demonstrated 2perceived exertion and 1oxygen
uptake.






1. The increase in systolic blood pressure induced by midodrine (10mg)
was significantly higher in the patient (change of 56mmHg) than in
controls (change of 15mmHg).
2. Midodrine and clonidine, either alone or in combination, led to
increased resting blood pressure and decreased severity of OH.
day
1. Fludrocortisone in both patients resulted in pitting edema of hands
and lower limbs. No effect of fludrocortisone on OH.
2. Initiation of the midodrine resolved orthostatic symptoms in both




1. Four patients on ephedrine commenced salt supplementation with
meals and 3 of these because independent of ephedrine use.
2. Low blood sodium found in 54% of the patients with OH and 16% of
those without; P.001 (suggests salt supplementation may be an
option for treatment).
3. Of 30 cases of subjects taking ephedrine, the authors state,
“Although a single dose of ephedrine in the morning was usually
sufficient, it was observed that some patients failed to recognize the




1. With decreasing ephedrine dose (and OH severity), there was 1mean
daily output of urine sodium (50–181mEq), 1 rate of creatinine
secretion, 1 rates of water excretion, 2 urine osmolality, and 1
sodium concentrations.
2. These results suggest that ephedrine can help to correct
hyponatremia; however, renal conservation of water still exceeded
that of sodium in 3 of the 4 patients.
3. Estimated daily intake of salt and water was inversely related to the
ephedrine requirement, which suggests that greater salt and water
intake may lead to more balanced renal action.
of
1. Gradual increase of midodrine dose from 2.5mg to 10mg (at 8:00 AM,
12:00 PM, and 4 PM) resulted in resolution of symptoms and
orthostasis. Patient became able to participate fully in rehabilitation
program.
1. After 10 days with fludrocortisone, patient able to tolerate sitting.




1. After salt supplement, a marked 1 in blood pressure and NE were
observed in response to sitting; a decrease in basal plasma renin
activity also was observed.
2. Addition of L-DOPS for 2 weeks resulted in a 5-fold to 10-fold
elevation in catecholamines (epinephrine and NE) without any
apparent increase in resting blood pressure.
3. Significant improvement in the symptoms of paroxysmal





















































































































































879ORTHOSTATIC HYPOTENSION AFTER SPINAL CORD INJURY, Krassioukovral and cranial blood vessels. Peak plasma levels are reached
bout 2 hours after ingestion. In a single case report, ergota-
ine was combined with fludrocortisone to prevent symptom-
tic OH successfully in 1 subject with SCI.25
Ephedrine. Ephedrine is a nonselective alpha and beta
eceptor agonist with both central and peripheral action. The
ose is 12.5 to 25mg orally 3 times a day. Side effects may
nclude tachycardia, tremor, and supine hypertension. Ephed-
ine raises blood pressure, both by increasing cardiac output
nd by inducing peripheral vasoconstriction, and it has a
lasma half-life ranging from 3 to 6 hours.51 Evidence from 2
evel 5 studies (retrospective chart reviews7,28) were found.
risbie28 reported that daily urinary output of salt and water
as inversely related to the prescribed ephedrine dose in 4
atients with OH. These results suggest that ephedrine can help
o correct hyponatremia; however, renal conservation of water
till exceeded that of sodium in 3 of the 4 patients. In their
bservational study, Frisbie and Steele7 reviewed 30 cases of
ubjects taking ephedrine and stated, “Although a single does
f ephedrine in the morning was usually sufficient, it was
bserved that some patients failed to recognize the need for a
epeated dose of this medication later in the day.”(p306)
L-threo-3,4-dihydroxyphenylserine. L-DOPS is an exoge-
ous, neutral amino acid, and a precursor of noradrenalin. Only
level 5 study has been published26 evaluating the effects of
-DOPS on OH, and this was in a single patient with nontrau-
atic SCI. In this study, treatment with salt supplementation in
ombination with L-DOPS resulted in a marked reduction of
yncopal attacks, decreased drowsiness associated with hypo-
ension, and increased daily activity.
harmacologic Management Conclusions
There is level 2 evidence22 that midodrine enhances exercise
erformance in some subjects with SCI, similar to other clin-
cal populations with cardiovascular autonomic dysfunction.
evertheless, it would be useful to confirm this evidence with
larger trial.
There is level 4 evidence,24 based on a single case series
nvolving 2 patients, that fludrocortisone is not effective for
H in patients with SCI. There is level 5 evidence25 that daily
rgotamine, combined with fludrocortisone, can successfully
revent symptomatic OH, but this is observed only in a single
ubject with SCI. There is level 5 evidence7 that ephedrine
educes the likelihood of a patient experiencing hypotension.
here is level 5 evidence,26 based on the results of a single case
tudy, that L-DOPS, in conjunction with salt supplementation,
ay be effective at reducing OH. Overall, for the studies
ssessing pharmacologic management of OH after SCI, the
evel of evidence ranges from level 2 to 5. Because there are
ew studies, all with very small sample sizes, it is clear that
urther research is necessary to confirm the benefits of these
harmacologic interventions for the treatment of OH.
onpharmacologic Management of Orthostatic
ypotension in Spinal Cord Injury
Of the nonpharmacologic studies, 3 involved the regulation
f fluid and salt intake, while 18 addressed physical modalities,
ike abdominal binders, physical activity, and electrical muscle
timulation.
luid and Salt Intake for the Management of Orthostatic
ypotension in Spinal Cord Injury
OH is common among persons with tetraplegia and high
araplegia, in whom symptoms are variable, and abnormal salt
nd water metabolism often coexist (table 1). Increases in fluid tntake and a high salt diet can expand extracellular fluid vol-
me and augment orthostatic responses. This simple interven-
ion appears to be effective in patients with idiopathic OH
ithout SCI.52,53 Frisbie and Steele7 reported that 3 of their 4
ubjects taking salt supplementation were able to become in-
ependent of the use of ephedrine. Frisbie28 further showed
hat the estimated daily intake of salt and water was inversely
elated to the ephedrine requirement in 4 patients with OH, and
uggested that greater salt and water intake may lead to more
alanced renal action.
ffect of Pressure Interventions in the Management of
rthostatic Hypotension in Spinal Cord Injury
The application of external counter-pressure by means of
evices like abdominal binders or pressure stockings is thought
o decrease capacitance within the lower extremity and abdom-
nal vasculature beds, which are major areas of blood pooling
uring standing (table 2). The studies examining pressure in-
erventions in patients with SCI generally have used a cross-
ver design to test different pressure conditions within the
ame group of participants (eg, with and without stockings) in
ither a random29,33 or nonrandom order.31,32,34
Because the studies did not assess the effects resulting from
ontinued use, long-term outcomes are uncertain, as are the
utcomes resulting from pressure removal after extended use.
he application of these interventions must therefore be inter-
reted with caution. Among 6 wheelchair athletes with para-
legia, Kerk et al32 found no statistically significant effects of
n abdominal binder used in the sitting position on any cardio-
ascular or kinematic variables at either submaximal or max-
mal levels of exercise. Similarly, in his review, Bhambhani54
oncluded that the use of abdominal binders in patients with
CI does not influence cardiovascular physiologic responses.
uang et al33 similarly reported that the use of assistive com-
ressive devices (inflatable abdominal corset, pneumatic leg
plints) do not improve pulmonary ventilatory parameters dur-
ng postural change. On the other hand, in a small group of 9
ubjects with SCI,30 stockings and an abdominal binder did
ecrease heart rate by 5 beats a minute and increase stroke
olume by 13mL/beat during submaximal upper-extremity ex-
rcises, but not during maximal exercises.29 In their study,
allbona et al34 observed a drop in systolic and diastolic blood
ressure during passive tilt in patients with tetraplegia and, in
ontrast, an increase in diastolic blood pressure among patients
ith paraplegia. Krassioukov and Harkema31 found that using
harness (which applies abdominal pressure) during locomotor
raining increased diastolic blood pressure in those with SCI,
ut not in able-bodied patients.
ffect of Functional Electrical Stimulation on Orthostatic
ypotension in Spinal Cord Injury
The application of FES activates the physiologic muscle
ump via intermittent muscle contractions around both the
uperficial and the deep veins of the legs, thereby facilitating
enous blood return (table 3). Several studies have demon-
trated that FES-induced contractions of the leg muscles in-
rease cardiac output and stroke volume, effects that are attrib-
table to increased venous return.36,42 The increases in
entricular filling and left ventricular end-diastolic volume may
enerate greater cardiac output and, as such, an increase in
rterial blood pressure. Therefore, FES-induced contraction of
he leg muscles may attenuate the drop in systolic blood pres-
ure that occurs in patients with SCI in response to an ortho-
tatic challenge, and may artificially restore the body’s ability
o return blood from below the level of the lesion back to the
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eart. In fact, FES may be effective during an orthostatic
hallenge by redistributing blood volume from the regions of
he body that are below the level of the SCI.40 FES of leg
uscles was shown to increase cardiac output and stroke
olume in 6 men with paraplegia while performing arm-crank
xercise at maximal effort. These results suggest that FES of
eg muscles may alleviate the lower-limb pooling that occurs
uring an orthostatic challenge. FES results in a dose-
ependent increase in blood pressure, independent of the
timulation site, so it may be useful in treating OH.37
FES may be an important treatment adjunct to minimize
ardiovascular changes during postural orthostatic stress in
ubjects with SCI. Three level 2 RCTs35-37 and 6 nonrandom-
zed trials4,38-42 provide support for the use of FES in subjects




Total Sample Size Methods




Population: 9 males: 5 with tetraplegi
8 complete, 1 incomplete.
Treatment: 5 discontinuous maximal
on different days while (1) sitting, (
plus an anti-gravity suit, (4) sitting
an abdominal binder, and (5) sitting
muscles.
Outcome measures: oxygen uptake, c
output, respiratory parameters, hea
pressure.




Population: 5 with tetraplegia, 4 with
subjects as Hopman et al29).
Treatment: 5 conditions as in Hopma
submaximal exercise at 20%, 40%,
power output.
Outcome measures: oxygen uptake, c
output, respiratory parameters, hea
pressure.




Population: 27 with tetraplegia; C4–C
of 47d postinjury; none had motor
slight sensory sparing in the sacral
Treatment: inflatable abdominal corse
pneumatic leg splints.
Outcome measures: respiratory rate,
rate, SBP, DBP.
Krassioukov and Harkema,31 2006; Canada
Downs and Black score17
Prospective controlled trial
N20
Population: 6 with complete tetrapleg
paraplegia, ASIA grade A; 9 able-bo
Treatment: with and without harness
training while supine, sitting, and s
subject analysis).
Outcome measures: blood pressure,
Kerk et al,32 1995; USA
Downs and Black score13
Prospective controlled trial
N6
Population: chronic complete paraple
Treatment: cross-over design: abdom
(experimental group) versus no abd
(controls).
Outcome measures: blood pressure,
oxygen consumption, respiratory p
wheelchair propulsion.
Vallbona et al,34 1963; USA
Downs and Black score13
Pre-post
N17
Population: 12 males with tetraplegia
females with paraplegia, ages 16 to
postinjury
Treatment: pressure suit (CSU-3/P an
inflated to a pressure of plus 30cm
Outcome measures: presence of sym
SBP and DBP during passive tilting
a motorized tilt table.
bbreviations: ASIA, American Spinal Injury Association; DBP, diastolic blood pressith SCI. FES may permit people with tetraplegia to experi- c
rch Phys Med Rehabil Vol 90, May 2009nce smaller hemodynamic changes with changes in posture,
nd consequently to stand up more frequently and for longer
urations.35,37 This effect may be more beneficial to those
ubjects with tetraplegia who have a compromised autonomic
ervous system and may not be able to adjust hemodynami-
ally to changes in position.4
ffects of Exercise on Orthostatic Hypotension in Spinal
ord Injury
After exercise, patients with SCI may exhibit positive
hanges in the autonomic regulation of their cardiovascular
ystems (table 4).43 Exercise or even passive movement of the
egs has the potential to stabilize the reduced central blood
olume that occurs in patients with SCI during an orthostatic






FES of the leg
dioxide
, blood
1. Supine posture increased peak oxygen uptake in tetraplegia,
but reduced heart rate in paraplegia compared to sitting.
2. There was no effect of the anti-G suit, stockings plus
abdominal binder, or FES on oxygen uptake, heart rate,
ventilatory exchange, or power output. The anti-G suit did
significantly reduce perceived exertion among subjects with
tetraplegia only.
3. Results suggest that there are no hemodynamic benefits of






1. Tetraplegia: 1 oxygen uptake, cardiac output, stroke volume,
blood pressure, and stroke volume with FES; 1 cardiac
output, 1 stroke volume, and 2 heart rate with binders and
stockings; 2 heart rate and 1 blood pressure with anti-G
suit.
2. Paraplegia: 1 oxygen uptake and 2 heart rate with FES; 2
oxygen uptake and 2 heart rate with anti-G suit; 2 oxygen






1. The use of assistive compressive devices does not improve
pulmonary ventilatory parameters during postural change.
2. Assistive devices had no effect on SBP except in the 20° and
45° head-up positions (P.01). In the 45° position, abdominal
corset was significantly better than pneumatic leg splints at
maintaining SBP. Same trend for DBP.
3. Both devices failed to influence heart rate 2 with 20° head-
down position. There was a significant effect of assistive







1. Orthostatic stress significantly decreased arterial blood
pressure only in subjects with cervical SCI (P.05).
2. Harness application had no effect on cardiovascular
parameters in able-bodied subjects, whereas DBP was
significantly increased in those with SCI.
3. Orthostatic changes in cervical SCI when sitting were
ameliorated by harness application. However, while standing






1. Five of 6 subjects demonstrated a mean increase of 31% in
forced vital capacity with binder, compared to without. No
statistical significance, but this may be because the sixth
subject experienced an 18% decrease in forced vital capacity







1. Presence of the suit attenuated the increase in heart rate
(P.20; not significant) and drop in SBP and DBP (P.005;
significant) during passive tilt in patients with tetraplegia.
2. In terms of heart rate and SBP, patients with paraplegia
responded to passive tilting in a pressure suit similarly to
passive tilting without the suit. However, an increase in DBP
comparable to that of subjects with tetraplegia wearing
pressure suits was observed.

































(withhallenge. For example, Dela et al55 noted a pronounced




Total Sample Size Methods Outcome




Population: 2 with tetraplegia, 3 with paraplegia, all complete, in acute period, 2–
4wk post-SCI.
Treatment: tilt table, 6min at each tilt angle (0°, 15°, 30°, 45°, 60°), with 4min of
recovery between each, with or without bilateral ankle plantar flexor and knee
extensor electrical stimulation.
Application order or absence of FNS was counterbalanced.
Outcome measures: heart rate, blood pressure, perceived exertion.
1. At tilt angles of 15°, 30°, 45°, and 60°, SBP was significantly lower when FNS was not applied
compared with when it was administered, and the difference was more marked with increasing tilt
angles.
2. There was a progressive decrease in blood pressures with increasing tilt angle, with this decrease less
pronounced in the FNS condition.
3. Post hoc analysis showed that heart rate was significantly higher with vs without FNS at 60° tilt.




Population: 7 with paraplegia, 7 with tetraplegia; 4 incomplete, 10 complete; able-
bodied, n15.
Treatment: random order of standing with or without FES (30min) for subjects with
SCI; voluntary tiptoe contractions during 30min standing for able-bodied subjects.
Outcome measures: hemodynamic parameters while supine-sitting-30min standing.
1. Reductions (P.05) of up to 10% blood pressure for subjects with SCI from sitting to passive standing,
but minimal changes when moving to FES standing.
2. After 30min passive standing (no FES), there was a reduction in stroke volume and cardiac output.
After 30min FES standing, prestanding hemodynamics were maintained, except for a significant
reduction in stroke volume.




Population: complete motor SCI (lesions above T6); 3 with recent injury, 3 with
long-standing injury. Treatment: with and without lower-extremity FES while
tilted in 10° increments every 3min, from 0° to 90° with varying intensities of
stimulation.
Outcome measures: blood pressure, heart rate, perceived syncope score.
1. 1 Heart rate in both groups with 1 incline angle. Mean DBP was lower in subjects with recent
(105mmHg) versus long-standing SCI (123mmHg).
2. 1 SBP and DBP with 1 stimulation intensities and 2 blood pressure with 1incline angle (P.001)
regardless of the site of stimulation.
3. Subjects tolerated higher angles of incline with FES than without. The higher the intensity of FES,
regardless of the stimulation site, the greater the tilt incline tolerated.
Faghri et al,4 2001; USA
Downs and Black score22
Prospective controlled trial
N14
Population: 7 with tetraplegia, 7 with paraplegia; 4 incomplete, 10 complete.
Treatment: FES-augmented standing (active) and non-FES standing (passive), for
30min; tests were separated by at least 24h.
Outcome measures: hemodynamic parameters.
1. Blood pressure changed 8% to 9% when moving from sitting to passive standing (no FES). The
augmented FES condition prevented blood pressure change when moving from sitting to standing.
Raymond et al,38 2002;
Australia
Downs and Black score16
Prospective controlled trial
N16 (8 SCI)
Population: 8 males with complete paraplegia, 8 male able-bodied controls.
Treatment: LBNP was used to provide the orthostatic challenge. Subjects were
evaluated (1) during supine rest, (2) supine with submaximal ACE, (3)
ACELBNP, and (4) for SCI only, ACELBNPleg ES.
Outcome measures: heart rate, stroke volume, cardiac output.
1. ES increased stroke volume from ACELBNP to ACELBNPES for both SCI and able-bodied groups;
ES did not affect oxygen uptake or cardiac output.
Raymond et al,42 1999;
Australia
Downs & Black score10
Prospective controlled trial
N  16 (8 SCI)
Population: 8 males with complete paraplegia, T5–T12, mean age, 41.36.5y, 3y
postinjury; 8 able-bodied controls.
Treatment: ES-induced leg muscle contractions during orthostatic challenge to
examine the effects on venous pooling.
Outcome measures: heart rate, SV, Q, SBP, DBP, MAP, limb volumes, V̇O2.
1. During orthostatic challenge, heart rate and V̇O2 did not differ significantly with ES compared to
without ES.
2. ES during orthostatic challenge augmented SV by 13mL/beat compared to without ES; Q increased by
0.7L/min. SBP, DBP, or MAP with ES did not change significantly.
3. ES elicited a significant reduction in calf volume during orthostatic challenge.
4. Even modest levels of ES provide a role in the assistance of blood redistribution from the lower limbs.
Faghri et al,39 1992; USA
Downs & Black score14
Pre-post
N13
Population: 6 with paraplegia (T4–T10); 7 with tetraplegia (C4–C7).
Treatment: FES-leg cycle ergometer training, 3 times a week, for about 12wk (36
sessions).
Outcome measures: V̇O2, V̇E, RER, blood pressure, heart rate, SV, and Q.
1. After training, 1 resting heart rate and SBP in subjects with tetraplegia and 2systolic and diastolic
blood pressure in subjects with paraplegia.
2. In both groups, heart rate and blood pressure during submaximal exercise significantly decreased, and
stroke volume and cardiac output significantly increased after program.
3. These results suggest that FES-LCE training improves peripheral muscular and central cardiovascular
fitness in subjects with SCI.
Davis et al,40 1990; USA
Downs & Black score16
Pre-post
N12
Population: 12 males with paraplegia (T5–L2); FES group, n6; no FES (control)
group, n6.
Treatment: submaximal and maximal ACE with or without FES of paralyzed leg
muscles.
Outcome measures: peak V̇O2, V̇E, perceived exertion RER, blood pressure, heart
rate, resting SV and Q, total peripheral resistance.
1. No significant differences between the FES and control groups in terms of peak V̇O2(2.09L/min),
maximal heart rate, V̇E, RER, or perceived exertion.
2. No differences in power output or V̇O2 during peripheral FES application, but stroke volume and Q
were higher during the FNS- induced leg contractions. Neither rest nor exercise heart rate was
significantly influenced by lower limb FES in the FES group.
3. Heart rate, SV, and Q were not significantly altered at rest or during hybrid exercise in controls. There
was a decrease in the peripheral and overall ratings of perceived exertion.
4. No changes in blood pressure, impedance indexes of myocardial contractility, or differentiated
subjective ratings of perceived exertion during hybrid exercise vs non-FES conditions.
Chao and Cheing,41 2005; China
Downs & Black score15
Post
N16
Population: complete motor tetraplegia.
Treatment: progressive head-up tilting maneuver with and without FES applied to 4
muscle groups.
Outcome measures: blood pressure, heart rate, perceived presyncope score.
1. With increasing tilt angle, 2 SBP and DBP and 1 heart rate with and without FES.
2. Adding FES to tilting significantly attenuated the drop in SBP by 3.71.1mmHg (P.005), the drop in
DBP by 2.30.9mmHg (P.018), and the heart rate increase by 1.00.5beats/min (P.039) for every 15°
increment in the tilt angle.
3. FES increased the overall mean standing time by 14.33.9min (P.003).
Abbreviations: ACE, arm crank exercise; DBP, diastolic blood pressure; ES, electrical stimulation; FNS, functional neuromuscular stimulation; LBNP, lower-body negative pressure; LCE, leg cycle ergometer; MAP, mean arterial pressure;
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ncrease in blood pressure in subjects with tetraplegia when their
egs were passively moved with a cycle ergometer. There also
s some evidence that exercise training can enhance sympa-
hetic outflow in patients with SCI, as shown by an increase in
atecholamine response to maximal arm ergometry exercises.56
o date, only 3 studies have attempted to assess the effects of
xercise on OH in patients with SCI. Lopes et al43 identified no
reatment effect of exercise on orthostatic tolerance when pa-
ients performed upper-extremity exercises during a progres-
ive vertical tilt protocol predominantly in subjects with tetra-
legia. In contrast, Engelke et al45 found a bout of maximal
rm-crank exercise did reduce the orthostatic hypotension in
ubjects with paraplegia during an orthostatic challenge given
4 hours after the exercise bout. It is likely that the differences
n results are in part a result of the level of paralysis. Ditor et
l44 demonstrated that 6 months of body weight support tread-
ill training did not improve orthostatic tolerance in a popu-
ation of persons with sensory-incomplete cervical SCI (C4–




Total Sample Size Methods




Population: 5 with tetraplegia, 1 wi
6 control subjects.
Treatment: random assignment to
exercise (60 bilateral forearm fle
extension movements a minute
first and third minute of each tilt
upper limb exercises during tilt f
by 10° increments at 5-min interv
blood pressure dropped below 7
Outcome measures: blood pressur
of hypotension.







Population: 10 sedentary subjects w
paraplegia, T1–T12, age 364y, 1
wheelchair use.
Treatment: maximal arm-crank exe
Outcome measures: blood pressur
forearm vascular resistance, and
hormone responses before and d
minutes of 70° HUT).






Population: sensory incomplete ce
level of injury C4–C5; ASIA grad
Treatment: 6mo BWSTT.
Outcomes measures: heart rate, bl
and orthostatic responses, heart
variability.
bbreviations: ASIA, American Spinal Injury Association; BWSTT,
ance; HUT, head-up tilt.5). Nonetheless, the authors found their results encouraging, i
rch Phys Med Rehabil Vol 90, May 2009ecause they suggest that orthostatic tolerance is retained after
xercise training.
onpharmacologic Management Conclusions
Level 5 evidence exists from 2 observational studies7,28 to
uggest that salt and fluid regulation, in combination with other
harmacologic interventions, may reduce the symptoms of OH.
owever, these conclusions should be interpreted with caution,
ecause no evidence exists on the effect of salt or fluid regu-
ation alone in the management of OH in patients with SCI.
urrently, guidelines that suggest appropriate water and salt
ntake specific to patients with SCI do not exist. There is level
evidence from a single lower-quality RCT that pressure from
lastic stockings and abdominal binders may improve cardio-
ascular physiologic responses during submaximal, but not
aximal, upper-extremity exercises. However, other studies
ave generated evidence that contradicts this. There is also
evel 2 evidence from small, lower-quality RCTs35-37 that FES










1. No significant difference between the active
upper-extremity exercise group versus the
nonexercise group with respect to tolerance






1. Heart rate increased similarly in the control
and postexercise conditions.
2. Reduction in SBP was significantly larger
during HUT before than after arm-crank
exercises (–12.04.6mmHg vs
–0.34.3mmHg).
3. Postexercise increase in FVR from supine to
HUT was significantly greater than increase
observed in control condition.
4. Carotid-cardiac baroreflex also increased
significantly after exercise.
5. No difference in vasoactive hormone
responses between the 2 conditions.
6. No difference in either leg compliance or




1. 2 Resting heart rate, but no change in blood
pressure after BWSTT.
1. No effect on blood pressure or heart rate
during the 60° Head Up Test.
2. A trend (P.09) toward a relative
exaggeration of the pressor response to
orthostatic stress during the tilt test
(measured by 2 low frequency power of
heart rate), suggesting improved orthostatic
tolerance.


















































































883ORTHOSTATIC HYPOTENSION AFTER SPINAL CORD INJURY, Krassioukovhanges during postural orthostatic stress in subjects with SCI.
evel 2 evidence exists that simultaneous upper-extremity ex-
rcises may increase orthostatic tolerance during a progressive
ilt exercise in subjects with paraplegia,45 but not tetraplegia.43
n addition, level 4 evidence44 exists that 6 months of body
eight support treadmill training does not substantially im-
rove orthostatic tolerance during a tilt test.
DISCUSSION
A systematic review of the literature found 26 articles eval-
ating pharmacologic and nonpharmacologic (fluid salt intake,
ressure interventions, FES, exercise) interventions (with some
tudies applying more than 1 of these interventions) for the
anagement of OH in persons with SCI. Overall, the quality of
he literature was poor. The pharmacologic interventions in-
luded 1 fair-quality RCT (using midodrine) with a PEDro
core of 5 of a maximum 10. The rest of the pharmacologic
tudies were of low quality with an average Downs and Black
core of 10 of a possible 28, and were primarily case series
sing retrospective data collected from a chart review. Simi-
arly, the nonpharmacologic RCTs had an average PEDro of 5
f 10, and the nonrandomized trials had an average of 14 of 28.
Despite the fact that a wide array of physical and pharma-
ologic measures have been recommended for the general
anagement of OH,17 very few have been rigorously evaluated
or use in SCI. Of the pharmacologic interventions, only for
inodrine is there supportive evidence from a low-quality RCT
level 2 evidence). Furthermore, the studies addressing the
harmacologic management of OH after SCI are few in number
nd small in terms of sample size, most involving 1 to a few
ubjects. Another problem with the literature involves combi-
ation therapies, because it invariably is difficult to determine
he effects of 1 medication when it is combined with others.
onetheless, it is reasonable to state that if nonpharmacologic
ethods to manage OH fail, midodrine might be considered for
he management of OH in persons with SCI, given its level 2
vidence. Clearly, further research is necessary to confirm any
eneficial effect midodrine has, and to assess the potential role
f numerous other pharmacologic interventions that have been
emonstrated to be efficacious for treatment of OH in other
onditions of orthostatic intolerance.
FES is one of the only nonpharmacologic interventions that
as some evidence (level 2) to support its utility. The use of
ES has been reported to be beneficial during the acute phase
f SCI in improving orthostatic tolerance during postural train-
ng, but retention and habituation of these effects are unknown.
or example, it is unknown whether muscle fatigue or habitu-
tion from the stimulation reduces the potential for longer use.
imilarly, after repeated bouts of FES, the potential retention of
he vascular benefits are unknown. Future research to address
hese gaps would provide valuable insight. More research is
lso required to determine the feasibility and practicality of
ES to reduce the effects of OH. In a review of nonpharma-
ologic interventions for OH post-SCI, Gillis et al46 stated that
FES of the legs holds the most promise”(p652) with an approx-
mate 8/4mmHg reduction in blood pressure fall during an
rthostatic challenge.
CONCLUSIONS
Although a wide array of physical and pharmacologic measures
re recommended for the general management of OH, very few
ave been evaluated for use in SCI. Because the mechanisms of
H are different in SCI than in other conditions, further research
eeds to quantify the treatments for OH in patients with SCI,
specially the many other pharmacologic interventions that have








● Syncope (temporary loss of consciousness)




● Loss of tonic sympathetic control56,57
● Altered baroreceptor sensitivity58,59
● Lack of skeletal muscle pumps10,36,38
● Cardiovascular deconditioning11,60
● Altered salt and water balance28
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